Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.22.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning Balance at Dec. 31, 2020 $ 16,650 $ 2,622 $ 91,523 $ (1,117) $ (76,378)
Beginning Balance , Shares at Dec. 31, 2020   261,907,622      
Stock-based compensation expense 310   310    
Exercise of stock options 267 $ 7 260    
Exercise of stock options , Shares   688,430      
Shares repurchased (534)   534    
Shares repurchased, Shares   (180,681)      
Gain on interest rate swap 319     319  
Net income (loss) 24,584       24,584
Ending Balance at Mar. 31, 2021 41,596 $ 2,629 91,559 (798) (51,794)
Ending Balance , Shares at Mar. 31, 2021   262,415,371      
Beginning Balance at Dec. 31, 2021 657,152 $ 3,007 752,343 225 (98,423)
Beginning Balance , Shares at Dec. 31, 2021   300,120,451      
Stock-based compensation expense 5,519   5,519    
Exercise of stock options $ 1,326 $ 15 1,311    
Exercise of stock options , Shares 1,486,727 1,486,727      
Gain on interest rate swap $ 1,869     1,869  
Net income (loss) 35,488       35,488
Ending Balance at Mar. 31, 2022 $ 701,354 $ 3,022 $ 759,173 $ 2,094 $ (62,935)
Ending Balance , Shares at Mar. 31, 2022   301,607,178